ALB Scotiabank Maintains Outperform Rating, May 2026

Scotiabank maintained its Outperform rating on Albemarle Corporation (ALB) on May 14, 2026, while raising its price target to $215 from $200. The specialty chemicals company trades at $191.10, reflecting recent market volatility in the lithium sector. Albemarle’s $22.5 billion market cap positions it as a key player in energy storage and electric vehicle supply chains. We examine what this maintained rating means for investors tracking the stock.

Scotiabank Maintains Outperform on ALB Analyst Rating

Scotiabank held firm on its Outperform rating for Albemarle, signaling confidence in the company’s long-term prospects despite near-term headwinds. The analyst firm raised its price target to $215 from $200, reflecting optimism about lithium demand recovery. This maintained stance suggests analysts believe current valuations offer opportunity for patient investors.

The rating action comes as ALB stock trades below its 50-day average of $182.12 and 200-day average of $134.76. Albemarle’s $1.62 dividend per share provides income support while the company navigates market cycles. Meyka AI rates ALB with a grade of B, reflecting balanced fundamentals against sector headwinds.

Financial Metrics Show Mixed Signals for ALB Stock

Albemarle’s financial profile reveals challenges offset by operational strengths. The company reports a price-to-sales ratio of 4.08 and price-to-book ratio of 2.28, indicating premium valuation relative to peers. Free cash flow per share stands at $4.90, supporting dividend sustainability despite negative earnings.

Operating margins remain thin at 5.55%, reflecting competitive pressures in specialty chemicals. However, the current ratio of 2.07 demonstrates solid liquidity for capital investments. Debt-to-equity of 0.19 provides financial flexibility as the company invests in lithium production capacity.

Lithium Market Dynamics Drive ALB Analyst Consensus

Analyst consensus on Albemarle reflects cautious optimism about lithium fundamentals. Among 27 tracked analysts, 16 rate the stock Buy, 10 rate it Hold, and 1 rates it Sell. This consensus score of 3.0 leans bullish despite recent stock weakness.

The specialty chemicals sector faces cyclical headwinds, yet long-term electric vehicle adoption supports lithium demand. Albemarle’s three-segment structure—Lithium, Bromine, and Catalysts—provides diversification. Revenue per share of $46.62 reflects the company’s scale in global markets.

Stock Performance and Technical Outlook for ALB

ALB declined 4.90% over the past day, trading near intraday lows of $188.30. Year-to-date performance shows +35.09% gains, though the stock remains 13.6% below its 52-week high of $221. Volume of 2.16 million shares traded slightly below the 30-day average, suggesting cautious positioning.

Technical indicators show mixed signals. The RSI at 48.83 indicates neutral momentum, while the ADX at 32.74 confirms a strong downtrend. Bollinger Bands suggest the stock trades near support at $184.75, offering potential reversal levels for traders.

Final Thoughts

Scotiabank’s maintained Outperform rating and raised price target reflect confidence in Albemarle’s lithium exposure despite near-term volatility. The $215 price target implies 12.6% upside from current levels, rewarding investors with conviction. With analyst consensus leaning bullish and the company maintaining financial flexibility, ALB offers a balanced risk-reward for long-term investors. However, cyclical headwinds and negative earnings warrant careful position sizing. Meyka AI’s B grade suggests holding current positions while monitoring quarterly earnings trends.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.